Liangcen Chen

1.4k total citations
9 papers, 1.1k citations indexed

About

Liangcen Chen is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Liangcen Chen has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 6 papers in Biomedical Engineering and 3 papers in Molecular Biology. Recurrent topics in Liangcen Chen's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). Liangcen Chen is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). Liangcen Chen collaborates with scholars based in China. Liangcen Chen's co-authors include Xianyi Sha, Xinyi Jiang, Xiaoling Fang, Hongliang Xin, Yanzuo Chen, Jijin Gu, Wei Zhang, Xiao Wang, Ye Jiang and Xiaoqing Ren and has published in prestigious journals such as Biomaterials and International Journal of Pharmaceutics.

In The Last Decade

Liangcen Chen

9 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangcen Chen China 9 764 569 454 113 109 9 1.1k
Mengyin Jiang China 11 563 0.7× 499 0.9× 367 0.8× 144 1.3× 104 1.0× 11 1.0k
Kairong Shi China 20 851 1.1× 825 1.4× 657 1.4× 83 0.7× 141 1.3× 25 1.4k
Émilie Allard-Vannier France 24 709 0.9× 656 1.2× 480 1.1× 110 1.0× 234 2.1× 45 1.5k
Deyu Miao China 9 481 0.6× 443 0.8× 324 0.7× 136 1.2× 92 0.8× 15 895
Haojun Ma China 21 750 1.0× 943 1.7× 517 1.1× 106 0.9× 116 1.1× 28 1.6k
Igor Skidan United States 9 588 0.8× 510 0.9× 293 0.6× 247 2.2× 173 1.6× 10 1.2k
Christian Ché Canada 6 444 0.6× 650 1.1× 213 0.5× 84 0.7× 177 1.6× 11 1.1k
Qin He China 20 1.1k 1.5× 962 1.7× 678 1.5× 165 1.5× 172 1.6× 27 1.7k
Zhilan Chai China 15 560 0.7× 572 1.0× 504 1.1× 93 0.8× 83 0.8× 16 1.1k
N. V. Nukolova Russia 15 732 1.0× 418 0.7× 462 1.0× 113 1.0× 165 1.5× 30 1.2k

Countries citing papers authored by Liangcen Chen

Since Specialization
Citations

This map shows the geographic impact of Liangcen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangcen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangcen Chen more than expected).

Fields of papers citing papers by Liangcen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangcen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangcen Chen. The network helps show where Liangcen Chen may publish in the future.

Co-authorship network of co-authors of Liangcen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Liangcen Chen. A scholar is included among the top collaborators of Liangcen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangcen Chen. Liangcen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jiang, Xinyi, Xianyi Sha, Hongliang Xin, et al.. (2013). Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel. Biomaterials. 34(12). 2969–2979. 72 indexed citations
2.
Jiang, Xinyi, Hongliang Xin, Jijin Gu, et al.. (2012). Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel. Biomaterials. 34(6). 1739–1746. 87 indexed citations
3.
Xin, Hongliang, Xianyi Sha, Xinyi Jiang, et al.. (2012). Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials. 33(32). 8167–8176. 255 indexed citations
4.
Jiang, Xinyi, Xianyi Sha, Hongliang Xin, et al.. (2011). Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Biomaterials. 32(35). 9457–9469. 94 indexed citations
5.
Xin, Hongliang, Xianyi Sha, Xinyi Jiang, et al.. (2011). The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ɛ-caprolactone) nanoparticles. Biomaterials. 33(5). 1673–1681. 111 indexed citations
6.
Gu, Jijin, Xiao Wang, Xinyi Jiang, et al.. (2011). Self-assembled carboxymethyl poly (l-histidine) coated poly (β-amino ester)/DNA complexes for gene transfection. Biomaterials. 33(2). 644–658. 53 indexed citations
7.
Xin, Hongliang, Xinyi Jiang, Jijin Gu, et al.. (2011). Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials. 32(18). 4293–4305. 311 indexed citations
8.
Jiang, Xinyi, Hongliang Xin, Xianyi Sha, et al.. (2011). PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: In vitro and in vivo evaluation. International Journal of Pharmaceutics. 420(2). 385–394. 55 indexed citations
9.
Xin, Hongliang, Liangcen Chen, Jijin Gu, et al.. (2010). Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. International Journal of Pharmaceutics. 402(1-2). 238–247. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026